Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

MapLight Therapeutics, Inc. (MPLT) vs Valneva SE Sponsored ADR (VALN)

MapLight Therapeutics, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. MapLight Therapeutics, Inc. and Valneva SE Sponsored ADR are of similar size ($589.8M and $587.7M). MapLight Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 65.3×. MapLight Therapeutics, Inc. has the higher net margin (0.00% vs −12.0%) and the lower return on invested capital (−348.4% vs 0.00%). Across the 12 metrics below, Valneva SE Sponsored ADR leads on 7 and MapLight Therapeutics, Inc. on 5.

Valuation

Metric MPLT VALN Biotechnology median
P/E n/m 65.32 7.88
P/S n/m 3.33 11.47
P/B 1.36 5.80 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 46.45 0.74
EV/Sales n/m 3.78 10.73
Earnings yield (404.49%) 1.53% (28.84%)
Free cash flow yield (36.85%) (10.77%) (23.03%)

Profitability

Metric MPLT VALN Biotechnology median
Gross margin — 38.28% 65.16%
Operating margin 0.00% 13.56% 0.00%
Net margin 0.00% (12.01%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (297.18%) 0.00% (57.72%)
Return on assets (124.79%) 0.00% (49.22%)
Return on invested capital (348.44%) 0.00% 0.00%

Growth

Metric MPLT VALN Biotechnology median
Revenue growth (TTM) — (53.16%) 5.64%
EPS growth (last fiscal year) 82.39% (805.88%) —
Revenue growth, 5-year CAGR — 9.41% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MPLT VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 16.52 2.16 4.73
Net debt to EBITDA 1.79 (1.15) 0.96

Dividend

Metric MPLT VALN Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric MPLT VALN Biotechnology median
Market cap 587.68m 589.78m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack